Coronavirus Covid-19 Information

NMIC Bulletin Vol. 23 No. 6 Update on management of atopic eczema

28 December, 2017

Update on management of atopic eczema

  • Atopic eczema (AE) is a common chronic inflammatory skin condition which can have a significant negative impact on quality of life
  • Topical therapies, which include emollients, topical corticosteroids and topical calcineurin inhibitors are the mainstay of mild to moderate AE therapy
  • Emollients improve epidermal skin barrier dysfunction and should be used even when the
    AE appears to be quiescent
  • Secondary infection should be considered in patients who do not respond to topical therapy